Wall Street Zen lowered shares of Deep Fission (NASDAQ:FISN – Free Report) from a hold rating to a sell rating in a research note issued to investors on Saturday morning,Wall Street Zen reports. A number of other research analysts have also weighed in on FISN. UBS Group set a $18.00 price target on shares of […]

Wall Street Zen cut shares of Gossamer Bio (NASDAQ:GOSS – Free Report) from a hold rating to a sell rating in a research note issued to investors on Sunday morning,Wall Street Zen reports. GOSS has been the subject of a number of other reports. Leerink Partners upgraded Gossamer Bio from a “market perform” rating to […]

Wall Street Zen downgraded shares of Baiya International Group (NASDAQ:BIYA – Free Report) from a sell rating to a strong sell rating in a research report report published on Saturday,Wall Street Zen reports. Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Baiya International Group in a report on Wednesday, June 24th. One […]

Wall Street Zen lowered shares of Workhorse Group (NASDAQ:WKHS – Free Report) from a sell rating to a strong sell rating in a research note released on Saturday,Wall Street Zen reports. Separately, Weiss Ratings upgraded shares of Workhorse Group from a “sell (e)” rating to a “sell (e+)” rating in a research note on Thursday, […]

Wall Street Zen cut shares of Contineum Therapeutics (NASDAQ:CTNM – Free Report) from a hold rating to a sell rating in a research report released on Saturday morning,Wall Street Zen reports. A number of other research firms also recently issued reports on CTNM. Weiss Ratings restated a “sell (d-)” rating on shares of Contineum Therapeutics […]

Wall Street Zen cut shares of Banc of California (NYSE:BANC – Free Report) from a sell rating to a strong sell rating in a research report released on Saturday,Wall Street Zen reports. Several other brokerages have also commented on BANC. Weiss Ratings lowered Banc of California from a “hold (c+)” rating to a “hold (c-)” […]

Wall Street Zen cut shares of Bluejay Diagnostics (NASDAQ:BJDX – Free Report) from a hold rating to a sell rating in a research note issued to investors on Monday,Wall Street Zen reports. Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Bluejay Diagnostics in a report on Wednesday, June 24th. One analyst has […]

Wall Street Zen cut shares of Genius Sports (NYSE:GENI – Free Report) from a sell rating to a strong sell rating in a research note published on Sunday,Wall Street Zen reports. Several other research firms have also recently commented on GENI. The Goldman Sachs Group restated a “buy” rating and issued a $10.50 target price […]

Wall Street Zen lowered shares of Gloo (NASDAQ:GLOO – Free Report) from a hold rating to a sell rating in a research note issued to investors on Sunday,Wall Street Zen reports. A number of other equities analysts also recently issued reports on the stock. Citigroup started coverage on shares of Gloo in a research note […]

Wall Street Zen cut shares of Generate Biomedicines (NASDAQ:GENB – Free Report) from a hold rating to a sell rating in a research report sent to investors on Saturday,Wall Street Zen reports. Other equities research analysts have also issued research reports about the company. HC Wainwright reiterated a “buy” rating and issued a $30.00 price […]

Wall Street Zen downgraded shares of Polyrizon (NASDAQ:PLRZ – Free Report) from a hold rating to a sell rating in a research report report published on Saturday,Wall Street Zen reports. Separately, Weiss Ratings lowered shares of Polyrizon from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Tuesday, September 1st. […]

Wall Street Zen lowered shares of BridgeBio Oncology Therapeutics (NASDAQ:BBOT – Free Report) from a sell rating to a strong sell rating in a research note published on Saturday morning,Wall Street Zen reports. Several other brokerages also recently commented on BBOT. Canaccord Genuity Group lowered their price objective on shares of BridgeBio Oncology Therapeutics from […]